Zetia Buyers Fight Quick Appeal Of Antitrust Class Cert.
A class of direct Zetia buyers accusing Merck and Glenmark Pharmaceuticals of conspiring to keep a generic version of the cholesterol drug off the market has urged the Fourth Circuit not...To view the full article, register now.
Already a subscriber? Click here to view full article